Dirk Voelkel

Managing Open Innovation in Biotechnology

Dirk Voelkel, T. Fetterhoff, Dirk Voelkel, 2006 .

Willebrand Factor-Cleaving Protease (ADAMTS13) Cloning, Expression and Functional Characterization of the von

Dirk Voelkel, H. Peter, B. Plaimauer, 2013 .

Optimization of an Antibody Light Chain Framework Enhances Expression, Biophysical Properties and Pharmacokinetics

M. Freissmuth, Dirk Voelkel, P. Douillard, 2019, Antibodies.

New infrared injection‐seeded optical parametric oscillator with high energy and narrow bandwidth output

Axel Kulcke, Dirk Voelkel, F. Huisken, 1993 .

IR spectroscopy of size-selected clusters at 3 μm wavelength

Axel Kulcke, M. Kaloudis, Dirk Voelkel, 1995 .

Development of Methods for the Selective Measurement of the Single Amino Acid Exchange Variant Coagulation Factor IX Padua

Dirk Voelkel, P. Monahan, R. Pachlinger, 2018, Molecular therapy. Methods & clinical development.

Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease

A. Iolascon, L. De Franceschi, Dirk Voelkel, 2022, Haematologica.

Role of the Cysteine 81 Residue of Macrophage Migration Inhibitory Factor as a Molecular Redox Switch.

P. Goettig, H. Brandstetter, Dirk Voelkel, 2018, Biochemistry.